Association between retinal artery lesions and nonalcoholic fatty liver disease by unknown
ORIGINAL ARTICLE
Association between retinal artery lesions and nonalcoholic fatty
liver disease
Wen Yang • Hongtao Xu • Xiaohong Yu •
Yuzhu Wang
Received: 6 October 2014 / Accepted: 7 January 2015 / Published online: 15 February 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Objective Retinal artery lesions have been reported to be
a risk marker of morbidity and mortality for cardiovascular
and cerebrovascular diseases in various study populations.
Nonalcoholic fatty liver disease (NAFLD) is also a risk
factor for cardiovascular disease. However, the relationship
between retinal artery lesions and NAFLD is less certain.
Methods Data were obtained from 2,454 patients who
attended their annual health examination (2,143 males and
311 females, aged 62.34 ± 10.03 years). NAFLD was di-
agnosed by hepatic ultrasonography. Retinal artery lesions
were diagnosed according to the criteria. Total plasma
cholesterol, plasma triglyceride and fasting glucose levels
were determined by using a multichannel analyzer; the
body mass index, systolic blood pressure, diastolic blood
pressure, incidence of hypertension and coronary artery
disease were measured or analyzed by statistical analysis.
Results Patients with NAFLD had older age and higher
values of BMI, systolic blood pressure, diastolic blood
pressure, fasting glucose, total cholesterol and triglycerides
and had a higher incidence of hypertension, coronary artery
disease and retinal artery lesions (p \ 0.01). Retinal artery
lesions were taken as a dependent variable, and age, gender,
BMI, systolic blood pressure, diastolic blood pressure,
fasting glucose, total cholesterol and triglyceride levels, and
NAFLD were taken as covariates. We found that age
C65 years (p \ 0.01, OR 1.968), being male (p \ 0.01,
OR 1.668), BMI C 25 (p \ 0.01, OR 0.743),
SBP C 140 mmHg (p \ 0.01, OR 1.368) and NAFLD
(p \ 0.01, OR 2.378) were significantly associated with a risk
of retinal artery lesions by binary logistic regression analysis.
Conclusions Patients with NAFLD were older and had
higher values for BMI, systolic blood pressure, diastolic
blood pressure, fasting glucose, total cholesterol and
triglycerides, and higher incidence of hypertension, coro-
nary artery disease and retinal artery lesions. NAFLD is a
risk factor for retinal artery lesions.
Keywords Nonalcoholic fatty liver disease  Retinal
artery lesions  Risk factor
Introduction
Nonalcoholic fatty liver disease (NAFLD) has been recog-
nized as the most common liver disease, with an estimated
prevalence of 20–30 % [1, 2]. NAFLD includes a spectrum
of hepatic dysfunctions ranging from simple steatosis to
nonalcoholic steatohepatitis (NASH), cirrhosis and hepato-
cellular carcinoma [3]. NAFLD is considered to be a hepatic
component of metabolic syndrome [4, 5]. It is associated
with obesity, dyslipidemia, type 2 diabetes and an increased
level of serum fatty acid, and it also predicts the clustering of
risk factors for cardiovascular disease [6–8].
Retinal artery lesions are associated with both prevalent
and incident metabolic syndrome [9, 10]. It has been
demonstrated that retinal artery lesions independently
predict incident clinical stroke and lacunar infarcts [11].
Several studies have demonstrated that retinal artery le-
sions independently predict ischemic heart disease and
heart-related death [12].
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Other studies have documented a significant association
between NAFLD and carotid artery intima media thick-
ness, an early indicator of subclinical atherosclerosis [13,
14]. Retinal artery lesions are part of cerebrovascular
atherosclerosis. Nevertheless, the relationship between
NAFLD and retinal artery lesions is not clear in large
samples, especially in the Chinese population. Therefore,
the present study aimed to extensively investigate the as-
sociation between ultrasonographically diagnosed NAFLD
and retinal artery lesions in a large middle-aged and elderly
Chinese population.
Subjects and methods
Study population and data collection: All of the subjects
were residents in the community whose health care was
provided by our hospital and initially attending their annual
health examination in 2012. Inclusion criteria were complete
available medical records; normal blood pressure [diastolic
blood pressure (DBP) of \90 mmHg and systolic blood
pressure (SBP) of \140 mmHg] or well-controlled hyper-
tension (DBP of\90 mmHg and SBP of\150 mmHg); and
no smoking or history of alcohol consumption. The hyper-
tensive patients were taking antihypertensive medication,
and all the observed subjects were taking acetylsalicylic acid
(100 mg/day). Exclusion criteria were the presence of he-
matological system diseases; past history of cancer; major
gastrointestinal surgery, including partial or total gastrecto-
my or colorectomy; pulmonary disease; nephrotic syndrome
or serum creatinine levels higher than 115umol/l; total par-
enteral nutrition; viral hepatitis, autoimmune hepatitis and
liver degeneration, etc.; and taking statin drugs or other drugs
that damage the liver. Diabetes mellitus was diagnosed ac-
cording to the 2009 American Diabetes Association diag-
nostic criteria [15]. Finally, 2,454 eligible subjects were
enrolled (2,143 males and 311 females, aged 62.34 ±
10.03 years). Verbal informed consent was obtained from
each subject and was recorded by the physician who ex-
plained the study procedures.
Clinical examination
All patients were required to refrain from exercise for
1 day prior to the examination. Blood pressure was mea-
sured in the right arm using a mercury sphygmomanometer
after 20 min of rest with the patient in a sitting position.
Standing height, body weight and waist circumference
were recorded for all subjects. Waist circumference was
measured with the measuring tape positioned midway be-
tween the lowest rib and the superior border of the iliac
crest as the patient exhaled normally. Body mass index
(BMI) was calculated as weight divided by height squared.
Biochemical analyses
The blood samples were drawn from the participating pa-
tients after an overnight fast of more than 12 h. The serum
levels of plasma creatinine concentration, blood urea ni-
trogen, total plasma cholesterol, plasma triglyceride and
fasting glucose were measured using a multichannel
analyzer (Roche Hitachi 737; Boehringer Mannheim Di-
agnostics, USA).
Diagnosis of NAFLD, hypertension and coronary artery
disease
The diagnosis of NAFLD was based on the criteria sug-
gested by the Chinese Liver Disease Association [16].
Ultrasonic examination was carried out by a trained ultra-
sonographist who was unaware of the results of the phy-
sical examination and biochemical analyses. Diffuse fatty
liver can be defined by abdominal ultrasonography with the
presence of at least two of three findings: ‘‘bright liver,’’
liver echo greater than that of the kidney, vascular blurring
and the gradual attenuation of far field ultrasound echo
[16]. The examination was performed using a Toshiba
Nemio 20 sonography machine with a 3.5-MHz probe
(Toshiba, Tokyo, Japan).
Hypertension was defined as a SBP ]140 mmHg or
DBP ]90 mmHg according to the Seventh Report of the
Joint National Committee [17], or when the patients had a
history of hypertension or were receiving antihypertensive
treatment.
The diagnostic criteria for coronary heart disease in-
cluded patients with previous onset of myocardial infarc-
tion, with angina symptoms or ECG changes at the same
time of more than 75 % narrowing of the coronary artery
confirmed by coronary angiography. The symptoms of
angina pectoris include chest pain, dyspnea, diaphoresis
and palpitation, and the changes in electrocardiograms in-
clude significant ST-T wave change or Q wave
presentation.
Assessment of retinal artery lesions
The eye fundus examination was carried out for all the
patients before ultrasonic examination by direct ophthal-
moscopy performed after pupil dilation. The ophthal-
mologists who conducted the ophthalmoscopy did not
know the patients’ ultrasonic examination results. For all
patients, the upper temporal quadrants and the first three
arterial branches were analyzed. The extent and severity of
atherosclerotic vascular lesions in the retinal arteries were
classified according to Scheie. Stage 1 is defined as a
broadening of the light reflex from the artery with minimal
or no arteriovenous compression. Stage 2 is defined as
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changes similar to those in stage 1, but more prominent. In
stage 3, the arteries have a ‘‘copper wire’’ appearance, the
arteriovenous compression is much greater, and serious
atherosclerotic changes of the retinal arteries are present.
Stage 4 is the most severe form of atherosclerosis of the
retinal arteries.
Statistical analysis
Data were expressed as mean ± SD or counts. Statistical
analysis was performed using SPSS version 16.0 (SPSS Inc.,
Chicago, IL), and the level of statistical significance was de-
fined as p \ 0.05. The independent-samples t test was used for
the comparisons of continuous data, while the chi-square test
was used for the comparisons of categorical variables. Binary
logistic regression analysis was used to determine the factors
that were associated with retinal artery lesions.
Results
Baseline characteristics
Among the 2,454 enrolled patients (2,143 males and 311
females, aged 62.34 ± 10.03 years), 872 (785 males and
97 females) met the diagnostic criteria for NAFLD; the
prevalence of NAFLD was 35.53 % (males 36.63 % and
females 31.19 %). The characteristics of the patients,
classified by the presence or absence of NAFLD, are pre-
sented in Table 1. Patients with NAFLD were older and
had higher levels of BMI, SBP, DBP, fasting glucose, total
cholesterol and triglyceride levels and had a higher inci-
dence of hypertension, coronary artery disease and retinal
artery lesions (p \ 0.01).
NAFLD and risk factors for retinal artery lesions
Binary logistic regression analysis was used to evaluate the
risk factors for retinal artery lesions. Retinal artery lesions
were taken as the dependent variable and age, gender, BMI,
SBP, DBP, fasting glucose, total cholesterol, triglyceride,
NAFLD and coronary artery disease were taken as covari-
ates. We found that age C65 years (p \ 0.01, OR 1.968),
being male (p \ 0.01, OR 1.668), BMI C 25 (p \ 0.01,
OR 0.743), SBP C 140 mmHg (p \ 0.01, OR 1.368) and
NAFLD (p \ 0.01, OR 2.378) were significantly associated
with the risk of retinal artery lesions (Table 2).
Discussion
The retinal artery is part of the cerebral circulation system
and offers an opportunity to explore atherosclerosis in the
small peripheral arteries noninvasively. An assessment of
the retinal artery may offer the opportunity to determine
the extent of atherosclerosis in human body.
NAFLD is a hepatic manifestation of the metabolic
syndrome and is closely related to other clinical features of
the metabolic syndrome; thus, cardiovascular disease is
increased in NAFLD, and NAFLD represents the main
cause of death in these patients. Patients with NAFLD have
significantly higher rates of prevalent coronary, cere-
brovascular and peripheral vascular disease than their
counterparts without NAFLD [18–21].
This research is a study on the community residents
whose health care was provided by our hospital. In our
study, the retinal artery lesions were significantly increased
in NAFLD patients; retinal artery lesions were associated
with age, being male, BMI, DBP, total cholesterol,
triglycerides and NAFLD, showing that NAFLD is asso-
ciated with cerebral atherosclerosis. Other research [22, 23]
has reported that retinal vascular changes are related to
NAFLD, which is similar to our results.
The mechanisms underlying the association between
retinal artery lesions and NAFLD are currently unclear. The
pathogenetic mechanism might include endothelial dys-
function, oxidative stress, inflammation, inflammatory cy-
tokines, dyslipidemia and glucose metabolism disorder [24].
Several studies have demonstrated that metabolic syn-
drome has important implications for the clinical results of
NAFLD patients [25–27] and that advanced forms of
NAFLD stimulate increasing insulin resistance and dys-
lipidemia. In this way, the progression of atherosclerosis is
accelerated. In our study, BMI, total cholesterol and
triglyceride levels, which are the components of metabolic
syndrome, were significantly increased in NAFLD patients.
Oxidative stress and inflammation are associated with
retinal artery lesions [26]. Increased oxidative stress and
subclinical inflammation, which are considered to be causal
factors in the progression from simple steatosis to more
advanced forms of NAFLD, may represent a possible
atherogenic mechanism linking NAFLD and retinal artery
lesions [27, 28].
Retinal artery lesions have been associated with blood
pressure [29]. In our research, this was only related to SBP,
but not to DBP, which may be because the hypertensive
patients who attended our annual health examination
tended to be elderly. Our results indicate that coronary
heart disease was not associated with retinal artery lesions,
which may be because the diagnoses of coronary heart
disease were mainly based on the medical history, symp-
toms and electrocardiograms, and only the subjects sus-
pected of having coronary artery disease were checked by
coronary angiography examination, not all of them.
Another possible mechanism linking NAFLD and reti-
nal artery lesions could be decreased plasma levels of
280 Hepatol Int (2015) 9:278–282
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adiponectin, an adipose-secreted cytokine with antiathero-
genic properties. It has been shown that hypoad-
iponectinemia closely correlates to NAFLD in obese
individuals, unrelated to insulin resistance and other
metabolic syndrome components [30, 31]. However,
adiponectin plays an active role in the pathophysiology of
atherosclerosis [32].
A few limitations warrant consideration. First, the
diagnosis of NAFLD was based on ultrasound imaging.
The patients did not undergo liver biopsy and histological
examination, which is the gold standard technique for
identifying steatosis. The sensitivity of ultrasonography in
detecting steatosis varies between 60 and 94 % and is
dependent on the degree of steatosis. Second, our research
was a single-center study; thus, our relatively small sample
size may have posed a limitation to the study. Therefore,
our findings need to be confirmed in multicenter and
prospectively designed studies. Finally, retinal artery
lesions were not observed dynamically; thus, it remains
unclear whether retinal artery occlusion increases
incrementally whether the patient’s condition progressively
deteriorates or not.
In conclusion, NAFLD is extremely common in the
middle-aged and elderly Chinese population. Patients with
NAFLD had older age and higher levels of BMI, SBP,
DBP, fasting glucose, and total cholesterol and triglyc-
erides, and they had higher incidences of hypertension,
coronary artery disease and retinal artery lesions. NAFLD
is a risk factor for retinal artery lesions. NAFLD may be
involved in the formation of cerebrovascular atheroscle-
rosis, and the prevention of NAFLD has an effect on the
prevention of cerebral vascular disease. Patients with
NAFLD should always be assessed for retinal artery lesions
to ensure early diagnosis and entry into proper and thor-
ough medical care.
Compliance with ethical requirements and Conflict of inter-
est The study was reviewed and approved by the Ethics and Re-
search Committee of the Navy General Hospital (Beijing, China), and
the reported investigations were carried out in accordance with the
principles of the Declaration of Helsinki as revised in 2004
Table 1 Characteristics of
study subjects according to the
presence of NAFLD
Data are presented as
mean ± SD unless otherwise
indicated
BMI body mass index, SBP
systolic blood pressure, DBP
diastolic blood pressure
Variables NAFLD absent (n = 1,582) NAFLD present (n = 872) p value
Age, years 61.94 ± 9.954 63.06 ± 10.127 0.008
Male, n 1,358 (85.84 %) 785 (90.02 %) 0.003
BMI, kg/m2 24.31 ± 2.90 26.19 ± 3.14 0.000
SBP, mmHg 130.08 ± 15.38 135.17 ± 14.68 0.000
DBP, mmHg 81.06 ± 8.70 83.82 ± 8.28 0.000
Fasting glucose, mmol/l 5.34 ± 1.19 5.56 ± 1.18 0.000
Total cholesterol, mmol/l 4.76 ± 1.12 4.89 ± 1.15 0.008
Triglycerides, mmol/l 1.35 ± 1.13 1.69 ± 1.37 0.000
Hypertension, n 406 (25.66 %) 304 (34.86 %) 0.000
Coronary artery disease, n 267 (16.88 %) 189 (21.67 %) 0.004
Diabetes mellitus, n 167 (10.56 %) 114 (13.07 %) 0.061
Retinal artery lesions, n 463 (29.27 %) 427 (48.97 %) 0.000
Stage 1 344 (21.74 %) 163 (18.69 %) 0.074
Stage 2 119 (7.52 %) 264 (30.27 %) 0.000
Table 2 The results of binary





Variable SE Wald p value OR 95.0 % CI
Lower Upper
Age, years \65 = 0, C65 = 1 0.092 54.434 0.000 1.968 1.644 2.356
Male, n Female = 0, male = 1 0.149 11.875 0.001 1.668 1.247 2.232
BMI, kg/m2 \25 = 0, C25 = 1 0.094 10.053 0.002 0.743 0.618 0.893
SBP, mmHg \140 = 0, C140 = 1 0.113 7.753 0.005 1.368 1.097 1.707
DBP, mmHg \90 = 0, C90 = 1 0.120 0.053 0.817 0.973 0.769 1.230
Fasting glucose, mmol/l \6.1 = 0, C6.1 = 1 0.118 2.842 0.092 0.819 0.649 1.033
Total cholesterol, mmol/l \25 = 0, C25 = 1 0.110 1.857 0.173 1.161 0.937 1.440
Triglycerides, mmol/l \5.69 = 0, C5.69 = 1 0.101 0.522 0.470 0.929 0.762 1.134
NAFLD, n Absent = 0, present = 1 0.096 82.027 0.000 2.378 1.972 2.868
Coronary artery disease Absent = 0, present = 1 0.102 0.614 0.433 0.923 0.757 1.127
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